Granted Patent
B2
US 8,153,797 · App. 12/160,403 · Granted Apr 10, 2012
Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
Assignee:
Neurosearch A/S
View Patent ↗
Loading inventors, assignments & file history…
Abstract
This invention relates to novel chromen-2-one derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
Claims (4)
1. A chemical compound, which is
exo-3-Bromo-7-(8-aza-bicyclo[3.2.1]oct-3-yloxy)-chromen-2-one
or a pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition, comprising a therapeutically effective amount of the compound exo-3-Bromo-7-(8-aza-bicyclo[3.2.1]oct-3-yloxy)-chromen-2-one, or a pharmaceutically acceptable salt thereof, together with at least one pharmaceutically acceptable carrier, excipient or diluent.
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 20, 2013
From: NEUROSEARCH A/S
To: ANIONA APS
Reel/Frame 030049/0894 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 14, 2008
From: PETERS, DAN; REDROBE, JOHN PAUL; NIELSEN, ELSEBET OSTERGAARD
To: NEUROSEARCH A/S
Reel/Frame 021234/0072 →
Priority Claims (1)
DK 2006 00233
· Feb 17, 2006
· national
Continuity (1)